[{"address1": "12770 High Bluff Drive", "address2": "Suite 150", "city": "San Diego", "state": "CA", "zip": "92130", "country": "United States", "phone": "(619) 949-3681", "website": "https://www.gyretx.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Gyre Therapeutics, Inc., a pharmaceutical company, engages in the development and commercialization of small-molecule, anti-inflammatory, and anti-fibrotic drugs targeting organ fibrosis. The company offers ETUARY (Pirfenidone), an anti-fibrotic drug approved for the treatment of idiopathic pulmonary fibrosis; and under Phase 3 trials for the treatment of pneumoconiosis. It is also involved in the development of F351 (Hydronidone), a structural derivative of ETUARY, under Phase 3 trials for the treatment of chronic hepatitis B (CHB)-associated liver fibrosis; and completed Phase 1 trials for the treatment of liver fibrosis associated with metabolic dysfunction-associated steatohepatitis. In addition, the company develops F573 is in Phase 2 clinical trials for the treatment of acute/acute-on-chronic liver failure. Further, its preclinical products include F230 for the treatment of pulmonary arterial hypertension; and F528 to treat chronic obstructive pulmonary disease. The company was founded in 2002 and is headquartered in San Diego, California. Gyre Therapeutics, Inc. operates as a subsidiary of GNI USA, Inc.", "fullTimeEmployees": 579, "companyOfficers": [{"maxAge": 1, "name": "Dr. Han  Ying Ph.D.", "age": 58, "title": "CEO & Director", "yearBorn": 1966, "fiscalYear": 2024, "totalPay": 397945, "exercisedValue": 0, "unexercisedValue": 3216}, {"maxAge": 1, "name": "Mr. Songjiang  Ma", "age": 68, "title": "President & Director", "yearBorn": 1956, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Ruoyu  Chen", "age": 53, "title": "Chief Financial Officer", "yearBorn": 1971, "fiscalYear": 2024, "totalPay": 285000, "exercisedValue": 0, "unexercisedValue": 6744174}, {"maxAge": 1, "name": "Mr. Weiguo  Ye", "age": 46, "title": "Chief Operating Officer", "yearBorn": 1978, "fiscalYear": 2024, "totalPay": 332619, "exercisedValue": 0, "unexercisedValue": 18899056}, {"maxAge": 1, "name": "Mr. Ping  Zhang", "age": 51, "title": "Executive Chair", "yearBorn": 1973, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 9, "boardRisk": 9, "compensationRisk": 9, "shareHolderRightsRisk": 7, "overallRisk": 9, "governanceEpochDate": 1746057600, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 8.85, "open": 8.74, "dayLow": 8.6, "dayHigh": 9.26, "regularMarketPreviousClose": 8.85, "regularMarketOpen": 8.74, "regularMarketDayLow": 8.6, "regularMarketDayHigh": 9.26, "payoutRatio": 0.0, "trailingPE": 185.2, "forwardPE": 20.130434, "volume": 73722, "regularMarketVolume": 73722, "averageVolume": 151622, "averageVolume10days": 97150, "averageDailyVolume10Day": 97150, "bid": 8.78, "ask": 11.16, "bidSize": 3, "askSize": 2, "marketCap": 868056512, "fiftyTwoWeekLow": 6.11, "fiftyTwoWeekHigh": 19.0, "priceToSalesTrailing12Months": 8.208029, "fiftyDayAverage": 9.3286, "twoHundredDayAverage": 11.6603, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 838480128, "profitMargins": 0.11427, "floatShares": 23374091, "sharesOutstanding": 93742600, "sharesShort": 2496324, "sharesShortPriorMonth": 1526887, "sharesShortPreviousMonthDate": 1741910400, "dateShortInterest": 1744675200, "sharesPercentSharesOut": 0.026600001, "heldPercentInsiders": 0.85012, "heldPercentInstitutions": 0.02004, "shortRatio": 9.49, "shortPercentOfFloat": 0.1419, "impliedSharesOutstanding": 93742600, "bookValue": 0.734, "priceToBook": 12.615804, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": 12085000, "trailingEps": 0.05, "forwardEps": 0.46, "lastSplitFactor": "1:15", "lastSplitDate": 1698710400, "enterpriseToRevenue": 7.928, "enterpriseToEbitda": 47.061, "52WeekChange": -0.41891003, "SandP52WeekChange": 0.08001411, "lastDividendValue": 3.6, "lastDividendDate": 1673568000, "quoteType": "EQUITY", "currentPrice": 9.26, "targetHighPrice": 20.0, "targetLowPrice": 20.0, "targetMeanPrice": 20.0, "targetMedianPrice": 20.0, "recommendationKey": "none", "numberOfAnalystOpinions": 1, "totalCash": 26671000, "totalCashPerShare": 0.285, "ebitda": 17817000, "totalDebt": 1598000, "quickRatio": 2.636, "currentRatio": 3.32, "totalRevenue": 105757000, "debtToEquity": 1.624, "revenuePerShare": 1.243, "returnOnAssets": 0.083850004, "returnOnEquity": 0.20238, "grossProfits": 101873000, "freeCashflow": -6002875, "operatingCashflow": -3641000, "revenueGrowth": 0.027, "grossMargins": 0.96327, "ebitdaMargins": 0.16847, "operatingMargins": 0.02379, "financialCurrency": "USD", "symbol": "GYRE", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Gyre Therapeutics, Inc.", "longName": "Gyre Therapeutics, Inc.", "exchange": "NCM", "messageBoardId": "finmb_100542295", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "marketState": "REGULAR", "corporateActions": [], "regularMarketTime": 1746724382, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1144848600000, "regularMarketChange": 0.40999985, "regularMarketDayRange": "8.6 - 9.26", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 151622, "fiftyTwoWeekLowChange": 3.15, "fiftyTwoWeekLowChangePercent": 0.5155483, "fiftyTwoWeekRange": "6.11 - 19.0", "fiftyTwoWeekHighChange": -9.74, "fiftyTwoWeekHighChangePercent": -0.5126316, "fiftyTwoWeekChangePercent": -41.891003, "dividendDate": 1673481600, "earningsTimestamp": 1739885400, "earningsTimestampStart": 1746701940, "earningsTimestampEnd": 1747915200, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": 0.05, "epsForward": 0.46, "fiftyDayAverageChange": -0.0685997, "fiftyDayAverageChangePercent": -0.0073536974, "twoHundredDayAverageChange": -2.4003, "twoHundredDayAverageChangePercent": -0.20585233, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "cryptoTradeable": false, "regularMarketChangePercent": 4.6327662, "regularMarketPrice": 9.26, "displayName": "Gyre Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-05-08"}]